Laboratory Corp. Of America Holdings Earnings

Laboratory Corp. Of America Holdings’s revenue jumped 9.51% since last year same period to $3527.3Mn in the Q2 2025. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated 5.45% jump in its revenue since last 3-months.

Laboratory Corp. Of America Holdings’s net profit jumped 15.88% since last year same period to $237.9Mn in the Q2 2025. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated 11.8% jump in its net profits since last 3-months.

Laboratory Corp. Of America Holdings’s net profit margin jumped 5.81% since last year same period to 6.74% in the Q2 2025. On a quarterly growth basis, Laboratory Corp. Of America Holdings has generated 6.02% jump in its net profit margins since last 3-months.

Laboratory Corp. Of America Holdings’s price-to-earnings ratio after this Q2 2025 earnings stands at 30.49.

Laboratory Corp. Of America Holdings’s earning per share (EPS) estimates for the current quarter stand at 4.11 - a -1.44% fall from last quarter’s estimates.

Laboratory Corp. Of America Holdings’s earning per share (EPS) estimates for the current year stand at 4.11.

Laboratory Corp. Of America Holdings’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Laboratory Corp. Of America Holdings has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Laboratory Corp. Of America Holdings declared 0.72 dividend per share during the earnings announcement for Q3 2025.